Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEM 1414 in Allergen-Induced Late Asthmatic Response in Mild Allergic Asthma
2008-005910-37Phase 2Completed
- Sponsor
- Memory Pharmaceuticals
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of MEM 1414 in allergic asthma (2 arms), sponsored by Memory Pharmaceuticals. Primary endpoint: Change in FEV1 during late asthmatic response. Started Nov 2008; status: completed.
02
Drugs
MEM 1414
03
Conditions
allergic asthma
Beyond the preview
Go deeper on 2008-005910-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005910-37.